At Home | What's New | Financials | In the Clinic | Governance | R&D

CODE OF ETHICS

This Code of Ethics applies to all employees of AutoImmune Inc. and to all members of its Board of Directors. This Code presents a broad overview of the principles governing such persons' responsibilities in the workplace and their dealings with and on behalf of AutoImmune, as well as their responsibilities to other officers, directors and employees of AutoImmune and to AutoImmune shareholders and other stakeholders.

THE CODE. AutoImmune is committed to maintaining stringent ethical standards and to developing safe and effective products. In this regard, in the course of their employment or service and in all of their dealings with and on behalf of AutoImmune, all employees and directors must continuously strive to:
  1. Act with honesty and integrity, avoiding actual or apparent conflicts of interest in personal and professional relationships.

  2. Provide full, fair, accurate, timely, and understandable disclosure in the periodic reports required to be filed by AutoImmune with the Securities and Exchange Commission and in AutoImmune's other public communications.

  3. Comply with applicable laws, rules and regulations of federal, state, provincial and local governments and other private and public regulatory agencies with jurisdiction.

  4. Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or allowing independent judgment to be subordinated.

  5. Respect the confidentiality of information acquired in the course of their work or service, except when authorized or otherwise legally obligated to disclose such information, and never use such information for personal advantage.

  6. Share knowledge and maintain skills important and relevant to their duties and responsibilities.

  7. Promote ethical behavior among persons in the work environment.

  8. Responsibly use and control all assets and resources employed by them or entrusted to them.

  9. Promptly report known or suspected violations of this Code.

  10. Promote accountability for adhering to this Code.
WAIVERS. Any waiver of this Code for executive officers or directors may be made only by AutoImmune's Board of Directors and shall be promptly disclosed to AutoImmune's shareholders, along with the reasons for the waiver. AutoImmune shall disclose such waiver in a Form 8-K that will be filed with the Securities and Exchange Commission within five business days after the waiver has been granted. Any waiver of this Code for non-executive officer employees may be made in such manner as AutoImmune's Board of Directors may determine.

ENFORCEMENT AND REPORTING. Persons who violate the principles of this Code will be subject to disciplinary action, which may include termination of employment or removal from the Board.

Employees may report questionable behavior or suspected violations of this Code to their immediate supervisor or the "Designated Person" under AutoImmune's Accounting Complaint Resolution Process. Directors may report questionable behavior or suspected violations of this Code to the chairman of the board or the Designated Person. In accordance with the Accounting Complaint Resolution Process, any questionable accounting, internal accounting controls, or auditing matters or theft or fraud should be reported to the Designated Person.

AutoImmune will not retaliate against any person for reporting questionable behavior or suspected violations of this Code. If a question arises as to whether this Code has been violated, it is AutoImmune's policy to employ a fair process to determine whether in fact such a violation has occurred.